Roche's patent pain to be Biocon's gain

Indian firm to soon launch copycat of anti-breast-cancer drug For Swiss pharma major Roche, not pursuing an Indian patent for its anti-breast-cancer drug, Herceptin, might mean a loss of millions......

India partly revokes Roche cancer drug patent

India has partly revoked patents granted to Roche Holding AG for its breast cancer drug Herceptin, a spokesman for the drugmaker confirmed on Sunday.Swiss newspaper Schweiz am Sonntag reported that......

'Judgment will ensure no ever-greening of patents'

Though the legal battle over Glivec’s patentability may be over for now, Y K Sapru, the man spearheading the fight against Swiss multinational Novartis, isn’t resting. Sapru, founder......

BDR wrestles Big Pharma in patents match

A month ago, Dharmesh Shah had enough time to spare for day-to-day activities of a lesser-known company -- BDR Pharma -- where he serves as chairman & managing director.However, in the last one......